SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

Sanofi-Aventis

Sanofi ($SNY) is trending amidst discussions of potential acquisitions and partnerships, particularly fueled by speculation from the Altimmune ($ALT) community regarding a possible buyout.  The community is weighing the potential benefits of partnerships with companies like $VKTX and $GUTS, while keeping a close eye on developments in the broader pharmaceutical sector and competitive dynamics with companies like $LLY and $NVO.

The Stellar network is an open source, distributed, and community owned network used to facilitate cross-asset transfers of value. Stellar aims to help facilitate cross-asset transfer of value at a fraction of a penny while aiming to be an open financial system that gives people of all income levels access to low-cost financial services. Stellar can handle exchanges between fiat-based currencies and between cryptocurrencies. Stellar.org, the organization that supports Stellar, is centralized like XRP and meant to handle cross platform transactions and micro transactions like XRP. However, unlike Ripple, Stellar.org is non-profit and their platform itself is open source and decentralized.   Stellar was founded by Jed McCaleb in 2014. Jed McCaleb is also the founder of Mt. Gox and co-founder of Ripple, launched the network system Stellar with former lawyer Joyce Kim. Stellar is also a payment technology that aims to connect financial institutions and drastically reduce the cost and time required for cross-border transfers. In fact, both payment networks used the same protocol initially.  Distributed Exchange Through the use of its intermediary currency Lumens (XLM), a user can send any currency that they own to anyone else in a different currency.  For instance, if Joe wanted to send USD to Mary using her EUR, an offer is submitted to the distributed exchange selling USD for EUR. This submitted offer forms is known as an order book. The network will use the order book to find the best exchange rate for the transaction in-order to minimize the fee paid by a user.  This multi-currency transaction is possible because of "Anchors". Anchors are trusted entities that hold people’s deposits and can issue credit. In essence, Anchors serves as the bridge between different currencies and the Stellar network.  Lumens (XLM) Lumens are the native asset (digital currency) that exist on the Stellar network that helps to facilitate multi-currency transactions and prevent spams. For multi-currency transactions, XLM is the digital intermediary that allows for such a transaction to occur at a low cost.  In-order to prevent DoS attacks (aka spams) that would inevitably occur on the Stellar network, a small fee of 0.00001 XLM is associated with every transaction that occurs on the network. This fee is small enough so it does not significantly affect the cost of transaction, but large enough so it dissuades bad actors from spamming the network.   Prior to Protocol 12, Stellar had a built-in inflation mechanism conceived to allow account holders to collectively direct inflation-generated lumens toward projects built on Stellar.  As the network evolved and grew, it became increasingly clear that inflation wasn’t working as intended — account holders either didn’t set their inflation destination or joined inflation pools to claim the inflation themselves, and the operational costs associated with inflation payments continued to rise — and so a protocol change to disable inflation was proposed, implemented, voted on by validators, and ultimately adopted as part of a network upgrade.  The inflation operation is now deprecated. https://developers.stellar.org/docs/glossary/inflation/

Stellar Lumens

XLM is trending amidst market volatility, with community members actively discussing potential accumulation opportunities and key support levels. Some traders are speculating on short-term price movements, while others maintain a long-term bullish outlook, emphasizing utility and future potential. Recent news around treasury initiatives and partnerships may also be contributing to the increased attention.

Sound Group, Inc. is global audio-centric social and entertainment company, which engages in the provision of an audio platform. It focuses on audio entertainment and social networking. The company was founded by Jinnan Lai and Ning Ding in November 2010 and is headquartered in Singapore.

Sound Group Inc - ADR

Sound Group Inc

Sound Group Inc ($SOGP) is trending amid discussions around option trading and potential for high ROI, with some traders pointing to actionable alerts for both calls and puts. While some community members express bullish sentiment with mentions of gearing up, buy zones, and positive earnings growth, others warn of potential pump-and-dump schemes due to its history and association with Asian-based companies. The stock's volatility and past performance are also being heavily debated.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is trending downwards as concerns emerge regarding decelerating growth in core markets and some analysts pointing to an unstable "boom-bust viral hit model". Despite strong user engagement and platform growth, the stock faces scrutiny over profitability and rising expenses, leading to a mixed sentiment among investors. Additionally, concerns about child safety and potential legal hurdles contribute to the negative pressure.

Bath & Body Works, Inc. is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. The company was founded by Leslie Herbert Wexner in 1963 and is headquartered in Columbus, OH.

Bath & Body Works Inc

BBWI is trending due to a mix of factors, including recent analyst upgrades, strong Q3 earnings, and raised full-year guidance. The community is discussing whether the recent surge is justified and if the stock is undervalued given its low P/E ratio and growth potential. Bullish sentiment is building around holiday sales expectations and the company's strategic initiatives, though some remain cautious.

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals ($IONS) is trending as discussions revolve around potential catalysts and upcoming FDA decisions, particularly for Olezarsen and Donidalorsen. Community sentiment seems positive, with some highlighting the company's innovative RNA-targeted approach and commercial growth potential; however, insider selling and competitor advancements are also being closely watched.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares

LABD is trending as the underlying, XBI, approaches multi-year highs, causing concern for current LABD holders. The community is discussing strategies for managing downside risk and potential exit points, with some expressing frustration. Traders are watching for a potential reversal, influenced by factors like earnings, trade tensions, and Fed policy.

BlackPearl.Chain is pushing decentralization into the future with a third-generation public blockchain. It’s network achieves blazing transaction speeds (Millions TPS) using Sharding and a VRF lightning-fast consensus mechanism built in-house. Finality is achieved in under three seconds with revolutionary P2P, Its speed and security make it the perfect platform for applications like digital asset trading, social media messaging, payment processing, supply chain tracking, and other high-scale use cases.

BlackPearl

BlackPearl (BPLC) is trending as community members express strong conviction in its long-term potential and future listings on major exchanges. Optimism is fueled by the project's team and perceived potential within the banking and monetary system, with some anticipating significant market cap growth. The conversation highlights both excitement for immediate gains and a belief in the project's long-term investment viability.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Luxembourg.

Spotify Technology S.A.

Spotify is trending as investors assess recent news, including international subscription price hikes and a potential slowdown in user growth. Community discussions revolve around the impact of these changes on revenue projections and the stock's valuation, with some anticipating analyst revisions and others expressing concerns. Additionally, news of a leadership transition with the CEO stepping down has prompted some uncertainty.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain and as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is experiencing heightened interest, with community members actively discussing recent price pumps and dumps, as well as the potential impact of the upcoming Goliath mainnet launch and staking rewards. Some traders express concerns about manipulation, while others remain optimistic about long-term growth and potential partnerships. The delisting of Binance futures seems to have removed a big obstacle to price discovery.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

Quanterix Corporation (Quanterix or the Company) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of...

IDEAYA Biosciences (NASDAQ:IDYA) Hits New 12-Month High - Time to Buy?

IDEAYA Biosciences (NASDAQ:IDYA) Hits New 12-Month High - What's Next...

Envestnet Asset Management Inc. Raises Stake in IDEAYA Biosciences, Inc. $IDYA

Envestnet Asset Management Inc. raised its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 12.1% during the second quarter, according to the company in its most recent Form 13F...

Research Analysts Set Expectations for IDYA FY2025 Earnings

IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) - Cantor Fitzgerald lifted their FY2025 earnings estimates for IDEAYA Biosciences in a report issued on Thursday, November 13th. Cantor Fitzgerald...

IDEAYA Biosciences, Inc. $IDYA Shares Acquired by Fiera Capital Corp

Fiera Capital Corp boosted its position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 26.6% during the 2nd quarter, according to the company in its most recent filing with the Securities...

Candriam S.C.A. Cuts Stock Position in IDEAYA Biosciences, Inc. $IDYA

Candriam S.C.A. cut its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 2.5% in the second quarter, according to its most recent disclosure with the SEC. The firm owned...

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Get Free Report) have earned an average recommendation of "Moderate Buy" from the sixteen analysts that are presently covering the stock, MarketBeat...

Mizuho Boosts IDEAYA Biosciences (NASDAQ:IDYA) Price Target to $46.00

Mizuho increased their target price on IDEAYA Biosciences from $44.00 to $46.00 and gave the stock an "outperform" rating in a report on Tuesday...

IDEAYA Biosciences (NASDAQ:IDYA) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded shares of IDEAYA Biosciences from a "hold" rating to a "buy" rating in a research note on Sunday...

Leerink Partnrs Has Positive Outlook of IDYA FY2025 Earnings

IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) - Leerink Partnrs raised their FY2025 earnings per share (EPS) estimates for shares of IDEAYA Biosciences in a research report issued to clients...

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. It focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

IDYA
Ideaya Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IDYA News

IDYAIdeaya Biosciences Inc